Skip to main content
OpenTrials
Completed

NCT Number: NCT03354364

Efficacy of Pea Hull Fiber in Chronic Disease

The purpose of this study is to determine the effects of daily consumption of snacks with and without pea hull fiber on gastrointestinal function, gastrointestinal symptoms, food intake, appetite, changes in fecal and microbial composition and activity. Fifty maintenance hemodialysis hemodialysis and CKD patients in stage 4 or 5 will be recruited to participate in a randomized, blinded, 13-week cross-over study evaluating snack foods containing 15 g/d of pea hull fiber.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–100 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Food Science and Human Department, Gainesville, Florida, United States

Loading trial locations.

About this study

Maintenance hemodialysis hemodialysis and CKD patients in stage 4 or 5 (n=50) will be recruited for the study. A randomized, controlled, double-blind, cross-over study will be carried out. Following a 1-week baseline, participants will be assigned to receive snacks with pea hull fiber or control followed by a 4-week wash-out period, and then crossed over to the second intervention. Snacks with added pea hull fiber (15 g/d) and control will be provided to participants in identical packaging. Participants will collect 4 days of stools during the baseline week, week 5, 9, and 13 and analyzed for mineral content. Microbiota composition will be analyzed including microbial diversity, qPCR to quantify changes and 16S rRNA sequencing to identify pea hull fiber effects on specific bacteria. Following baseline, participants will attend a second visit and anthropometric and demographic information will be collected and we will measure blood pressure, the body composition by bioelectrical impedance analysis (BIA), and handgrip strength using a dynamometer.

Throughout the study, participants must complete a daily questionnaire to evaluate the transit time (eg. Bristol Stool Scale), stool frequency, and compliance. Every week, questionnaires to evaluate appetite (eg. SNAQ) and GI wellness (eg. GSRS - Gastrointestinal Symptom Response Scale) will be administered. During each study visit, participants will complete a questionnaire to evaluate the quality of life. In addition, the dietary data (24-hour diet recalls) will be collected by phone during the baseline week and during the last week of each period. During baseline, treatment and each washout, fasting blood will be collected and analyzed for a comprehensive metabolic panel with eGFR, in addition to microbial metabolites (e.g., indoxyl sulfate and p-cresyl sulfate), and inflammatory markers (e.g. CRP, TNFα, IL-6).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-85 years of age.
  • Kidney disease stage 4 or 5 (including dialysis).
  • Willing and able to complete the Consent Form in English.
  • Willing to have height, weight, blood pressure, handgrip strength, and body composition measured and provide demographic information (e.g. age, race, sex).
  • Willing to consume pea hull fiber snack or control snack for a 56-day period, 28 day for each type of snack.
  • Willing to complete a daily, and weekly, and monthly questionnaires regarding appetite, wellness, and transit time, and quality of life throughout the entire 13-week study.
  • Willing to provide three 24-hr diet recalls by phone during baseline and last week of each period.
  • Willing to provide 16 days of stools and 4 blood samples throughout the study.

Exclusion criteria

  • Do not meet the above criteria.
  • Have known gastrointestinal disease (i.e., inflammatory bowel disease, malignancy, celiac disease), previous colorectal surgery.
  • Allergies to ingredients in study foods provided.
  • Are pregnant or lactating

Treatment and study plan

Pea hull fiber

Dietary Supplement

Snacks containing 15 g/day of ground pea hulls.

Control

Dietary Supplement

Snacks without added fiber.

Primary outcomes

  1. Uremic molecule - p-cresyl sulfate

    Time frame: baseline, 5 weeks, 9 weeks, 13 weeks

    Change in serum levels of microbial metabolic product, p-cresyl sulfate

Secondary outcomes

  1. Uremic molecules (various)

    Time frame: baseline, 5 weeks, 9 weeks, 13 weeks

    Change in serum levels microbial metabolic products (e.g. indoxyl sulfate, TMAO, phenylacetyl glutamine etc.)

  2. Fecal content of metabolites and minerals

    Time frame: at baseline, week 5, week 9 and week 12.

    Change in fecal concentration of microbial metabolites and minerals

  3. Number of stools per week

    Time frame: 13 weeks

    Change in number of stools per week and mean number of stools per week per period

  4. Stool form rating

    Time frame: 13 weeks

    Change in stool form determined using Bristol Stool Form Scale

  5. Gastrointestinal symptom score

    Time frame: at weeks 1 through 13

    Change in gastrointestinal symptom score determined by GSRS (Gastrointestinal Symptom Response Scale)

  6. Fecal microbiota profile changes

    Time frame: baseline, weeks 5, 9 and 13

    change at phylum and genus levels; changes in operational taxonomic units (OTUs)

  7. Dietary intake

    Time frame: baseline, weeks 5, 9 and 13

    Change in dietary energy, macronutrient and fiber intake

  8. Appetite

    Time frame: at weeks 1 through 13

    Change in appetite determined by SNAQ questionnaire

  9. Quality of Life

    Time frame: baseline, weeks 5, 9 and 13

    Change in Kidney Disease Quality of Life questionnaire (KDQOL®-36)

Sponsors and collaborators

Lead sponsor

University of Florida

Other

Collaborators

  • Saskatchewan Pulse Growers

Registry information

Official study title

Efficacy of Pea Hull Fiber Supplementation on Gastrointestinal Transit Time-induced Reduction in Proteolytic Fermentation and Enhancement of Wellness in Individuals With Lifestyle-related Chronic Disease and Overweight. (Phase 3)

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Nov 27, 2017
Registry last updated
Sep 25, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.